K Tsuchida1, Y Takemoto, T Nakamura
1Division of Artificial Kidney, Osaka City University Hospital, Osaka, Japan.
Dialysis related amyloidosis (DRA) treatment may benefit from Lixelle hemoperfusion, which removes beta2-microglobulin (beta2M) and inflammatory cytokines. This adsorbent shows high efficiency in clearing key cytokines linked to DRA development.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: